{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Moreover , all adenosine receptor agonists : 2 - p - ( 2 - carboxyethyl ) phenethylamino - 5 ' - N - ethylcarboxamidoadenosine ( CGS 21680 ) , A2A receptor agonist , N6 - cyclopentyladenosine ( CPA ) , A1 receptor agonist , and 5 ' - N - ethylcarboxamidoadenosine ( NECA ) , A2 / A1 receptor agonist significantly and dose - dependently decreased cocaine - induced locomotor activity .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| Cocaine-induced locomotor activity |\n\nIn this paragraph, the disease entity is \"cocaine-induced locomotor activity\". The other mentioned entities are not diseases but specific compounds that affect this disease."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| Cocaine-induced locomotor activity |\n\nIn this paragraph, the disease entity is \"cocaine-induced locomotor activity\". The other mentioned entities are not diseases but specific compounds that affect this disease."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Moreover , all adenosine receptor agonists : 2 - p - ( 2 - carboxyethyl ) phenethylamino - 5 ' - N - ethylcarboxamidoadenosine ( CGS 21680 ) , A2A receptor agonist , N6 - cyclopentyladenosine ( CPA ) , A1 receptor agonist , and 5 ' - N - ethylcarboxamidoadenosine ( NECA ) , A2 / A1 receptor agonist significantly and dose - dependently decreased cocaine - induced locomotor activity .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| 2 - p - ( 2 - carboxyethyl ) phenethylamino - 5 ' - N - ethylcarboxamidoadenosine ( CGS 21680 ) |\n| A2A receptor agonist |\n| N6 - cyclopentyladenosine ( CPA ) |\n| A1 receptor agonist |\n| 5 ' - N - ethylcarboxamidoadenosine ( NECA ) |\n| A2 / A1 receptor agonist |\n| cocaine |\n\nThe paragraph mentions several specific chemical compounds: CGS 21680, CPA, NECA, and cocaine. These are the valid chemical entities from the paragraph. The names of the receptors (A1 and A2) are not chemical entities and do not need to be included in the table."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| 2 - p - ( 2 - carboxyethyl ) phenethylamino - 5 ' - N - ethylcarboxamidoadenosine ( CGS 21680 ) |\n| N6 - cyclopentyladenosine ( CPA ) |\n| 5 ' - N - ethylcarboxamidoadenosine ( NECA ) |\n| cocaine |\n\nThe paragraph mentions several specific chemical compounds: CGS 21680, CPA, NECA, and cocaine. These are the valid chemical entities from the paragraph. The names of the receptors (A1 and A2) are not chemical entities and do not need to be included in the table."}
  ]
}